Lack of association of RAD51 genetic variations with hepatitis B virus clearance and occurrence of hepatocellular carcinoma in a Korean population

Journal of Medical Virology

Volumn 83, Issue 11, 2011, Pages 1892-1899

  Pasaje, Charisse Flerida A ^a   Kim, Jeong Hyun ^a   Park, Byung Lae ^b   Cheong, Hyun Sub ^b   Bae, Joon Seol ^a   Park, Tae Joon ^a   Lee, Jin Sol ^a   Kim, Yongha ^a   Lee, Hyo Suk ^c   Koh, Insong ^d   Kim, Yoon Jun ^a,c   Shin, Hyoung Doo ^a,b  

^a Sogang University   (South Korea)

^b SNP Genetics ^*  (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Hanyang University   (South Korea)

Author keywords

HCC; RAD51, HBV; Single nucleotide polymorphism, haplotype

Indexed keywords

RAD51 PROTEIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; DNA REPAIR; EXON; FEMALE; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INTRON; KOREA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROMOTER REGION; VIRAL CLEARANCE; VIRUS CARRIER;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HEPATITIS B; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RAD51 RECOMBINASE;

HEPATITIS B VIRUS;

EID: 80052768913     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22122     Document Type: Article

References (30)

1. Ahn YO. 1996. Strategy for vaccination against hepatitis B in areas with high endemicity: Focus on Korea. Gut 38: S63-S66.
2. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
3. Baumann P, Benson FE, West SC. 1996. Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell 87: 757-766.
4. Beasley RP, Hwang LY, Lin CC, Chien CS. 1981. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2: 1129-1133.
5. Benson FE, Stasiak A, West SC. 1994. Purification and characterization of the human Rad51 protein, an analogue of E. coli RecA. EMBO J 13: 5764-5771.
6. Bill CA, Summers J. 2004. Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration. Proc Natl Acad Sci USA 101: 11135-11140.
7. Capovilla A, Carmona S, Arbuthnot P. 1997. Hepatitis B virus X-protein binds damaged DNA and sensitizes liver cells to ultraviolet irradiation. Biochem Biophys Res Commun 232: 255-260.
8. Charames GS, Bapat B. 2003. Genomic instability and cancer. Curr Mol Med 3: 589-596.
9. Compton SA, Ozgur S, Griffith JD. 2010. Ring-shaped Rad51 paralog protein complexes bind Holliday junctions and replication forks as visualized by electron microscopy. J Biol Chem 285: 13349-13356.
10. Connell PP, Jayathilaka K, Haraf DJ, Weichselbaum RR, Vokes EE, Lingen MW. 2006. Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers. Int J Oncol 28: 1113-1119.
11. Cousineau I, Abaji C, Belmaaza A. 2005. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: Implications for sister chromatid cohesion, genome stability, and carcinogenesis. Cancer Res 65: 11384-11391.
12. Ferguson DO, Rice MC, Rendi MH, Kotani H, Kmiec EB, Holloman WK. 1997. Interaction between Ustilago maydis REC2 and RAD51 genes in DNA repair and mitotic recombination. Genetics 145: 243-251.
13. Golub EI, Gupta RC, Haaf T, Wold MS, Radding CM. 1998. Interaction of human rad51 recombination protein with single-stranded DNA binding protein, RPA. Nucleic Acids Res 26: 5388-5393.
14. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, Edler L, Lubinski J, Scott RJ, Hamann U. 2007. The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev 16: 270-275.
15. Jakubowska A, Narod SA, Goldgar DE, Mierzejewski M, Masojc B, Nej K, Huzarska J, Byrski T, Gorski B, Lubinski J. 2003. Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland. Cancer Epidemiol Biomarkers Prev 12: 457-459.
16. Ko JC, Ciou SC, Cheng CM, Wang LH, Hong JH, Jheng MY, Ling ST, Lin YW. 2008. Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells. Carcinogenesis 29: 1448-1458.
17. Levy-Lahad E, Lahad A, Eisenberg S, Dagan E, Paperna T, Kasinetz L, Catane R, Kaufman B, Beller U, Renbaum P, Gershoni-Baruch R. 2001. A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc Natl Acad Sci USA 98: 3232-3236.
18. Lio YC, Schild D, Brenneman MA, Redpath JL, Chen DJ. 2004. Human Rad51C deficiency destabilizes XRCC3, impairs recombination, and radiosensitizes S/G2-phase cells. J Biol Chem 279: 42313-42320.
19. Mitra A, Jameson C, Barbachano Y, Sanchez L, Kote-Jarai Z, Peock S, Sodha N, Bancroft E, Fletcher A, Cooper C, Easton D, Eeles R, Foster CS. 2009. Overexpression of RAD51 occurs in aggressive prostatic cancer. Histopathology 55: 696-704.
20. Nyholt DR. 2004. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74: 765-769.
21. Ouyang KJ, Woo LL, Zhu J, Huo D, Matunis MJ, Ellis NA. 2009. SUMO modification regulates BLM and RAD51 interaction at damaged replication forks. PLoS Biol 7: e1000252.
22. Ryder SD. 2003. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 52: 1-8.
23. Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989.
24. Tong S, Li J, Wands JR. 1999. Carboxypeptidase D is an avian hepatitis B virus receptor. J Virol 73: 8696-8702.
25. Valerie K, Povirk LF. 2003. Regulation and mechanisms of mammalian double-strand break repair. Oncogene 22: 5792-5812.
26. Vispe S, Defais M. 1997. Mammalian Rad51 protein: A RecA homologue with pleiotropic functions. Biochimie 79: 587-592.
27. Wang WW, Spurdle AB, Kolachana P, Bove B, Modan B, Ebbers SM, Suthers G, Tucker MA, Kaufman DJ, Doody MM, Tarone RE, Daly M, Levavi H, Pierce H, Chetrit A, Yechezkel GH, Chenevix-Trench G, Offit K, Godwin AK, Struewing JP. 2001. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev 10: 955-960.
28. Wiese C, Collins DW, Albala JS, Thompson LH, Kronenberg A, Schild D. 2002. Interactions involving the Rad51 paralogs Rad51C and XRCC3 in human cells. Nucleic Acids Res 30: 1001-1008.
29. Willers H, Taghian AG, Luo CM, Treszezamsky A, Sgroi DC, Powell SN. 2009. Utility of DNA repair protein foci for the detection of putative BRCA1 pathway defects in breast cancer biopsies. Mol Cancer Res 7: 1304-1309.
30. Zanetti AR, Tanzi E, Romano L, Grappasonni I. 1993. Vaccination against hepatitis B: The Italian strategy. Vaccine 11: 521-524.